Welcome to AIMday Predictive Health Analytics
Queen’s University Belfast will be hosting AIMday Predictive Health Analytics on 27th November 2024 at Riddel Hall, bringing together academics, industry professionals, and clinical consultants to deliberate on the potential for predictive analytics in the Northern Ireland health service.
AIMday Predictive Health Analytics is organised by the Mathematical Sciences Research Centre in association with Momentum One Zero, and is funded by the International Centre for Mathematical Sciences.
Momentum One Zero is a £70m flagship global innovation centre spearheaded by Queen’s University Belfast as part of the Belfast Region City Deal and is set to reshape Northern Ireland’s digital landscape, addressing business and societal challenges in key sectors, including digital health. Establishing multidisciplinary partnerships, the centre seeks to capture the full potential for data-driven insights and solutions in healthcare, building upon an established foundation of university research excellence in health innovation, predictive modelling and data science.
This event will feature insightful case studies and interactive breakout sessions focusing on industry-proposed challenges to ignite discussions on the potential for predictive health analytics in Northern Ireland by bringing together the ingenuity of the private sector and creativity and expertise of academics.
We would love you to come along to our event and discuss how we can work together.
What is AIMday?
AIMday® (Academic Industry Meeting day) is a successful, proven format based on workshops where challenges submitted by participating companies around a central theme are discussed with academics from relevant university disciplines.
Read more about the AIMday Concept.
Predictive Health Analytics – An Opportunity for Innovation
Predictive health analytics is a powerful tool that represents a significant opportunity to enhance patient care, optimise operational efficiency, and incorporate precision medicine approaches to improve patient outcomes. Innovation in technology has led to the accumulation of vast amounts of data, the analysis and modelling of which has the potential to provide significant benefits to the healthcare service through data-driven insights. Studies estimate that similar innovations in the US healthcare system could save up to $150 billion annually.
In 2022, HSCNI released the Data Strategy 2022 – 2030 which outlines their data vision for the NI health service:
“To make HSC a data and insight driven organisation that improves people’s lives through the use of data.”
Part of this ambition includes the recent launch of Encompass, the new digital health and care record system, which will provide a single digital care record for every citizen. Such consolidation and linkage of data provides great potential for future data-driven health innovations in Northern Ireland.
This AIMday will serve as a platform to initiate discussions on the utilization of statistical modelling, operational research, Artificial Intelligence, and machine learning techniques in a healthcare context to optimize the impact of advanced health analytics research. For instance, the workshop will concentrate on various aspects, including but not limited to, the use of predictive analytics to:
- Enhance clinical decision-making for improved patient care
- Identify at-risk patients for early interventions
- Facilitate precision medicine approaches
- Facilitate effective and efficient operational decisions
- Adapt statistical and machine learning techniques for near real-time insights
This event will bring companies with industry-led challenges in Predictive Health Analytics into contact with a strong network of leading academics, building upon an established foundation of university research excellence in health innovation and predictive modelling. Taking advantage of existing strengths and capitalising on the diverse expertise across the university, this event provides the mechanism to create innovative solutions and spark future joint multidisciplinary partnerships.
Our Expertise
Northern Ireland is a one of the UK’s leading regions for the life and health sciences industry, delivering innovative products and services to global customers in precision medicine, diagnostics, connected health, and health analytics. Such industry expertise aligns well with the cutting-edge research currently being undertaken across multiple Faculties within Queen’s University Belfast.
This AIMday will bring together research groups from various disciplines, including experts in statistics, machine learning, experimental medicine, public health, operational research, data science, computer science and artificial intelligence. Such a range of expertise, joint with the ingenuity of the private sector, is necessary to achieve sophisticated solutions to health challenges for the benefit of patients, both responsibly and effectively, to deliver real value for the Northern Ireland health service.
Scientific excellence
Queen’s University Belfast has an established foundation in health innovation, developing new avenues for the prevention, diagnosis and treatment of health problems that affect millions of people globally. Through inter-disciplinary research, Queen’s leading academics deliver translational solutions and insightful discoveries, merging expertise across medicine, statistics, operational research and computer science to achieve real-world impacts.
Through the Belfast Region City Deal, Queen’s University Belfast are working with our partners to deliver a transformational £230m programme of innovation through data-driven Innovation Centres, two of which have key strategic objectives in health innovation:
- iREACH Health, who are committed to addressing major health challenges in clinical research through the development of medicines, technologies and therapies, and,
- Momentum One Zero, who are committed to innovation in digital health through data-driven insights
These centres build on the impactful work of the university’s established, leading research groups who tackle challenges across healthcare, including:
- Wellcome-Wolfson Institute for Experimental Medicine, who are committed to research excellence in experimental medicine, making breakthroughs in the mechanisms of disease,
- Patrick G Johnston Centre for Cancer Research, who are committed to finding new ways to advance and tackle cancer care through personalised treatments,
- Centre for Public Health, who are committed to advancing the health of the public by influencing clinical and public health practice and policy, and,
- Mathematical Sciences Research Centre, who are committed to developing new statistical, mathematical and operational research solutions providing insights into patient care and operational challenges.
Industry focus and commercialisation capability
Queen’s University Belfast has a strong track record in the production of intellectual property and creation of spinout companies, ranked 2nd in the UK for Entrepreneurial Impact (Octopus Ventures, 2022). This is achieved through renowned innovation programmes which are vital for translating research into real-world benefits and fostering an innovation ecosystem through partnerships, such as Innovate UK’s Innovation to Commercialisation of University Research (ICURe) programme.
Queen’s University Belfast is one of the leading universities in the UK for Knowledge Transfer Partnerships, an Innovate UK initiative which provides funding to embed academic expertise into a company, stimulating business growth and powering innovation excellence. For the business, this drives a competitive advantage, routinely delivering new products and increasing efficiency and productivity.
A key objective of Momentum One Zero is to equip the regional economy to seize the opportunities of the data revolution, assisting companies to grow and diversify based on digital innovation. Our world leading expertise is aligned and will be enhanced with the new City Deal Investment in innovation infrastructure that will help de-risk and accelerate healthcare innovation in Northern Ireland, enabling improved patient outcomes and quicker routes to commercialisation.
How to participate
To join in with us at our AIMDay event, please submit one or more challenges phrased as a question, which you wish to discuss with our team in a small workshop setting.
Each question submitted by a company is tackled by a group of multi-disciplinary academics with the aim of finding pathways to solutions.
One question, one hour, a group of academic experts: that is the AIMday format!
Important Dates
Company registration opens: Tuesday 27th August 2024
Questions submission (company/organization registration) deadline: Monday 30th September 2024
Academic researchers’ sign-up open: Wednesday 23rd October 2024
Academic researchers’ sign-up deadline: Friday 15th November 2024
Meeting Day: Wednesday 27th November 2024
Contact Us
For more information or for support to develop your research question, please contact: businessalliance@qub.ac.uk